Home › Funds › SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC › ORKA

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC position in ORKA

ORUKA THERAPEUTICS INC · Health Care

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC reported holding 723,922 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$60.3M, representing 1.80% of its reported portfolio and ranking #10 among its reported holdings. SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC has disclosed ORKA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)723.92K sh
Reported value held$60.30M
Portfolio Weight1.80%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC's ORKA position evolved

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC first disclosed a stake in ORKA in Q2 2026 at 658,301 shares (US$62.7M). Across 2 filings, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 723,922 shares valued at US$60.3M — an increase of 65,621 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 658.30K $62.65M New
Q3 2026 723.92K $60.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 76 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$261.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC held ORKA?

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC has disclosed ORKA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC's current position in ORKA?

As of Q3 2026, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC holds 723.92K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $60.30M, representing 1.80% of its reported portfolio and ranking #10.

Has SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC been buying or selling ORKA?

In the latest 13F filing (Q3 2026), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC increased its position in ORKA.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 76 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.